Walgreens

Ferrous Gluconate

Serving

1 Tablet(s)

Form

tablet

DSLD

26615

Formula hash

a6e1241be449

Brand context

Walgreens

Catalog

products

With avoid flag

products

FDA recalls

history

CAERS

reports

Avoid-flaggedObjective label signals

Flagged excipients

1 avoid · 2 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

2 active ingredients

Ingredient	Amount	% DV
Iron mineralUNII · E1UOL152H7 UL · set5 effects	27 mg	150%
Sodium mineralUNII · 9NEZ333N27	0 mg	0%

What this product supports · authorized claims

5 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

↑Normal formation of red blood cells + hemoglobin
from: Iron
EFSAEU-Reg-432/2012-ID-249 →LOINC 789-8
↑Normal cognitive function
from: Iron
EFSAEU-Reg-432/2012-ID-253 →
↑Normal oxygen transport in the body
from: Iron
EFSAEU-Reg-432/2012-ID-252 →LOINC 718-7
↑Normal immune system function
from: Iron
EFSAEU-Reg-432/2012-ID-254 →
↓Reduction of tiredness and fatigue
from: Iron
EFSAEU-Reg-432/2012-ID-255 →

Flagged excipients

3 flagged · authority citations

● AVOIDTitanium Dioxide
color
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
◐ CAUTIONFD&C Yellow #5 Lake
color
EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).
eur-lex.europa.eu →ecfr.gov →
◐ CAUTIONFD&C Blue #1 Lake
color
EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.
eur-lex.europa.eu →

FDA CAERS · adverse event context

consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Ferrous Gluconate · Dicalcium Phosphate · Microcrystalline Cellulose · Croscarmellose Sodium · Hypromellose · Crospovidone · Stearic Acid · Propylene Glycol · Magnesium Stearate · Polyethylene Glycol · Silicon Dioxide · Sodium Lauryl Sulfate